Results 91 to 100 of about 2,380,407 (323)

Methods of Technical Prognostics Applicable to Embedded Systems [PDF]

open access: yes, 2012
Hlavní cílem dizertace je poskytnutí uceleného pohledu na problematiku technické prognostiky, která nachází uplatnění v tzv. prediktivní údržbě založené na trvalém monitorování zařízení a odhadu úrovně degradace systému či jeho zbývající životnosti a to ...
Krupa, Miroslav
core  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Energy-Efficient CNN Hardware Accelerator for Real-Time Construction Progress Monitoring

open access: yesIEEE Access
Real-time construction progress monitoring is a critical but resource-intensive task for autonomous edge devices. Traditional deep learning approaches face limitations in terms of computational power and energy consumption, which hinder their on-site ...
George B. Nardes   +4 more
doaj   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Kalman Filter With Dynamical Setting of Optimal Process Noise Covariance

open access: yesIEEE Access, 2017
We propose a dynamical way to set the process error covariance matrix (Q) for a constant velocity (CV) model Kalman filter. We are able to achieve the best possible solution for the estimated state, in the sense of forecast error, while significantly ...
Gabriel F. Basso   +3 more
doaj   +1 more source

Model based code generation for distributed embedded systems [PDF]

open access: yes, 2010
Embedded systems are becoming increasingly complex and more distributed. Cost and quality requirements necessitate reuse of the functional software components for multiple deployment architectures.
Delange, Julien   +4 more
core   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

Scheduling the Exchange of Context Information for Time-Triggered Adaptive Systems

open access: yesAlgorithms
This paper presents a novel metascheduling algorithm to enhance communication efficiency in off-chip time-triggered multi-processor system-on-chip (MPSoC) platforms, particularly for safety-critical applications in aerospace and automotive domains.
Daniel Onwuchekwa   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy